Clinical Outcomes with Biosimilars: Do They Work as Well as the Original Biologics?
Dec 26 2025
The 80-125% Rule: Understanding Bioequivalence Confidence Intervals
Explains the 80-125% bioequivalence rule, clarifying that it measures drug absorption rates (AUC/Cmax) via 90% confidence intervals, not ingredient amounts. Covers exceptions for NTI drugs and common misconceptions.
